Using Topology To Revolutionize Atrial Tachycardia Treatment

The project aims to develop and validate a diagnostic tool, Directed Graph Mapping, to enhance the accurate diagnosis and treatment of atrial tachycardia, improving ablation strategies and outcomes.

Subsidie
€ 150.000
2024

Projectdetails

Introduction

Atrial tachycardia (AT) is a prevalent form of supraventricular tachycardia that can have detrimental impacts on a person's health. The complexity of anatomical reentry patterns and unclear nomenclature hinders precise diagnosis of AT and makes optimal treatment challenging and error-prone. Suboptimal treatment can result in severe outcomes such as heart failure, stroke, and pacemaker implantation due to overablation-induced atrial dysfunction.

Proposed Solution

In this proposal, we introduce a diagnostic tool called Directed Graph Mapping (DGM), which offers a unique classification system based on clear and precise mathematical criteria using topological principles. This allows for the accurate diagnosis and differentiation of various types of AT.

Features of DGM

  • DGM can automatically analyze a given case of AT, providing consistent and reliable results.
  • It paves the way for the optimization of the ablation strategy.
  • DGM can not only diagnose the current AT but also predict hidden slower ATs, which might appear depending on the chosen ablation target.

By being able to predict the hidden ATs, we can revolutionize the treatment of ATs, as these hidden ATs can be treated already after the measurement of the first anatomical map. Therefore, our tool holds the potential to significantly expedite the ablation procedure.

Study Proposal

We propose to conduct a prospective study involving a minimum of 15 hospitals in Belgium that specialize in AT ablations. This study aims to further validate the effectiveness and sustainability of our proposed solution while involving a broad range of electrophysiologists. We aim to publish our results in a high-impact journal.

Intellectual Property and Market Interest

We secured the intellectual property rights of our proof-of-concept through two patents. By discussing with electrophysiologists, we learned that their interest in DGM influences mapping systems. If they recognize the value of DGM for treating AT, mapping companies may adopt the technology through a licensing agreement, which is the final goal of this proposal.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 150.000
Totale projectbegroting€ 150.000

Tijdlijn

Startdatum1-1-2024
Einddatum30-6-2025
Subsidiejaar2024

Partners & Locaties

Projectpartners

  • UNIVERSITEIT GENTpenvoerder

Land(en)

Belgium

Vergelijkbare projecten binnen European Research Council

ERC Consolid...

Translational optoelectronic control of cardiac rhythm in atrial fibrillation

This project aims to develop a shock-free, optoelectronic method for controlling cardiac rhythm in atrial fibrillation using engineered 3D heart models and advanced monitoring systems.

€ 1.999.999
ERC Advanced...

Unique non-invasive pace-mapping system to identify subjects at risk of arrhythmic sudden death

Develop a non-invasive mapping and pacing system to detect cardiac signals for predicting sudden cardiac death, improving early diagnosis and management of heart disease.

€ 2.488.400
ERC Proof of...

A Chemogenetic Approach for the Treatment of Atrial Fibrillation

Develop a targeted, non-destructive chemogenetic treatment for atrial fibrillation to safely modulate cardiac excitability and prevent atrial remodeling.

€ 150.000
ERC Starting...

Reversible and irreversible cardiac electroporation: Establishing the fundamentals to advance cardiac treatments

This project aims to understand cardiac electroporation mechanisms to develop methods for effective irreversible and reversible treatments for atrial fibrillation and ischemic heart disease.

€ 1.500.000
ERC Starting...

Engineering vasoactive probes for brain-wide imaging of molecular signaling

This project aims to develop AVATars that convert neurotransmitter signaling into hemodynamic signals for enhanced fMRI, enabling visualization of molecular dynamics in brain function.

€ 1.492.968

Vergelijkbare projecten uit andere regelingen

Mkb-innovati...

De ontwikkeling van een slimme katheter

Dit project ontwikkelt een slimme hartkatheter en een realistisch testplatform om de efficiëntie van katheterablatie te verbeteren, wat leidt tot meer kennis en werkgelegenheid in Zuid-Nederland.

€ 132.538
Mkb-innovati...

CARTBox Cardiale ablatie

CART-Tech onderzoekt de haalbaarheid van een nieuwe module voor hun CARTBox-software, gericht op het verbeteren van de effectiviteit en veiligheid van cardiale ablaties door MRI- en CT-beeldanalyse.

€ 20.000
EIC Transition

Transcription Factor Gene Therapy for Bradyarrhythmias

PacingCure's TRACTION project aims to optimize and validate BradyTx-01, a gene therapy for cardiac pacing dysfunctions, ensuring safety, efficacy, and a pathway to commercialization.

€ 2.499.968
Mkb-innovati...

Laesy Visualisatie 2.0

Het project Laesie Visualisatie 2.0 ontwikkelt software voor verbeterde visualisatie van hartweefsel, wat leidt tot efficiëntere behandeling van hartritmestoornissen en lagere gezondheidskosten.

€ 162.190
Mkb-innovati...

Beeldgestuurde oplossingen in de cardiologie en neurologie. Innovatieve weefselherkenning en 4D-monitoring van resultaten bij patiënten

Dit project ontwikkelt een cloudplatform voor 3D-beeldbewerking en 4D-analyse om gepersonaliseerde revalidatie en succesvolle pacemakerimplantaties te verbeteren in cardiologie en neurologie.

€ 262.962